|
PSRC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.23809962282451E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.73819999999392E-05 |
| Normal-vs-Stage2 |
6.05080000000147E-05 |
| Normal-vs-Stage3 |
6.14989999999649E-05 |
| Normal-vs-Stage4 |
3.683300E-03 |
| Stage1-vs-Stage2 |
2.821800E-02 |
| Stage1-vs-Stage3 |
3.237400E-03 |
| Stage1-vs-Stage4 |
1.163200E-01 |
| Stage2-vs-Stage3 |
6.924800E-01 |
| Stage2-vs-Stage4 |
9.477600E-01 |
| Stage3-vs-Stage4 |
7.195600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.38110017550753E-10 |
| Normal-vs-AfricanAmerican |
8.07840000000004E-05 |
| Normal-vs-Asian |
5.894100E-02 |
| Caucasian-vs-AfricanAmerican |
3.486800E-01 |
| Caucasian-vs-Asian |
5.360600E-01 |
| AfricanAmerican-vs-Asian |
2.774800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.60649998543528E-09 |
| Normal-vs-Female |
6.63579999948816E-07 |
| Male-vs-Female |
4.795600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.34599999999752E-05 |
| Normal-vs-Extreme_Weight |
2.406200E-04 |
| Normal-vs-Obese |
5.3837000002499E-07 |
| Normal-vs-Extreme_Obese |
6.685800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.168800E-01 |
| Normal_Weight-vs-Obese |
7.727200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.208400E-02 |
| Extreme_Weight-vs-Obese |
2.603800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.331600E-01 |
| Obese-vs-Extreme_Obese |
4.863700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.404000E-04 |
| Normal-vs-Age(41-60Yrs) |
6.54709997327529E-09 |
| Normal-vs-Age(61-80Yrs) |
2.20799999950394E-07 |
| Normal-vs-Age(81-100Yrs) |
9.177600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.690000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.859020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.344230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.104200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.178800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.364800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.477799989277E-09 |
| Normal-VS-Type2 PRCC |
2.803600E-03 |
| Normal-VS-KIRP CIMP |
3.000900E-04 |
| Normal-VS-Unclassified PRCC |
2.34229999999114E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.640800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.0536000000515E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
7.863700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.833100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.700400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.887900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.58260000000011E-05 |
| Normal-vs-N1 |
7.30550000049845E-07 |
| Normal-vs-N2 |
2.746600E-01 |
| N0-vs-N1 |
1.717980E-03 |
| N0-vs-N2 |
4.854200E-01 |
| N1-vs-N2 |
9.133600E-01 |
|
|
